9-(p-DIMETHYLAMINOANILINO)ACRIDINE

Suppliers

Names

[ CAS No. ]:
13365-38-3

[ Name ]:
9-(p-DIMETHYLAMINOANILINO)ACRIDINE

[Synonym ]:
ACRIDINE,9-(p-DIMETHYLAMINOANILINO)
9-(p-Dimethylaminoanilino)acridine
WIN 1701
N'-9-Acridinyl-N,N-dimethyl-1,4-benzenediamine
9-((p-(Dimethylamino)phenyl)amino)acridine
9-[(4-Dimethylamino-phenyl)-amino]-acridin
Acridine,9-((p-(dimethylamino)phenyl)amino)

Chemical & Physical Properties

[ Density]:
1.229g/cm3

[ Boiling Point ]:
490.2ºC at 760 mmHg

[ Molecular Formula ]:
C21H19N3

[ Molecular Weight ]:
313.39600

[ Flash Point ]:
250.3ºC

[ Exact Mass ]:
313.15800

[ PSA ]:
28.16000

[ LogP ]:
5.27060

[ Vapour Pressure ]:
9.34E-10mmHg at 25°C

[ Index of Refraction ]:
1.748

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AR9100000
CHEMICAL NAME :
Acridine, 9-(p-dimethylaminoanilino)-
CAS REGISTRY NUMBER :
13365-38-3
LAST UPDATED :
199612
DATA ITEMS CITED :
7
MOLECULAR FORMULA :
C21-H19-N3
MOLECULAR WEIGHT :
313.43
WISWESSER LINE NOTATION :
T C666 BNJ IMR DN1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80970 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation) Behavioral - convulsions or effect on seizure threshold Cardiac - pulse rate
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
35 mg/kg/28D-I
TOXIC EFFECTS :
Cardiac - arrhythmias (including changes in conduction) Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
35 mg/kg/28D-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Gastrointestinal - changes in structure or function of salivary glands Blood - pigmented or nucleated red blood cells

MUTATION DATA

TYPE OF TEST :
DNA damage
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
2 umol/L
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 24,170,1981

Safety Information

[ HS Code ]:
2933990090

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • 9-(p-Vinylphenyl)anthracene
  • 9-(p-methylbenzylidene)-9,10-dihydroanthracene
  • 9-(p-tolyl)-2,3-dihydrocyclopenta[c]furo[3,2-g]chromen-4(1H)-one
  • 9-(p-Nitrobenzyl)-9H-purin-6-ol
  • 9-((p-formyl)phenyl)-10-bromoanthracene
  • 9-(p-Tolyl)carbazole
  • 2-chloro-6-fluoro-N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)benzamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-2-(trifluoromethyl)benzamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-3-(trifluoromethyl)benzamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-4-(trifluoromethyl)benzamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-1-naphthamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-2-naphthamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-[1,1'-biphenyl]-4-carboxamide
  • 2-(2-fluorophenoxy)-N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)acetamide
  • 2-(4-fluorophenoxy)-N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)acetamide
  • N-((1-(3-fluorophenyl)-1H-tetrazol-5-yl)methyl)-2-(4-methoxyphenyl)acetamide